Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Clinical trial NCT00411580 · COMPLETED
Trial details
- NCT number
- NCT00411580
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2008-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.